DQB INTERNATIONAL

Lobbying Income

Filings

Unique Clients

Active Period

2004–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	—	2	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	2	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	2	1
2006	$0	2	2
2005	—	2	2
2004	—	2	2

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
TEXAS BIOMEDICAL RESEARCH INSTITUTE	—	40	2016–2026
NOVARTIS AG	$0	2	2005–2006
OTO MELARA	—	1	2004
FINMECCANICA	—	25	2004–2012

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	29
HOUSE OF REPRESENTATIVES	28
Defense, Dept of (DOD)	2
Energy, Dept of	2
Natl Institutes of Health (NIH)	2
Homeland Security, Dept of (DHS)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	27
Budget/Appropriations	Budget/Appropriations	7
Defense	Defense	6
Aerospace	Aerospace	6
Science/Technology	Science/Technology	4
Economics/Economic Development	Economics/Economic Development	3
Health Issues	Health Issues	2
Energy/Nuclear	Energy/Nuclear	2
Disaster Planning/Emergencies	Disaster Planning/Emergencies	1
Aviation/Airlines/Airports	Aviation/Airlines/Airports	1
Telecommunications	Telecommunications	1
Transportation	Transportation	1
Railroads	Railroads	1

DQB INTERNATIONAL — Lobbying Disclosure | Poliscope